PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 3 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 1 year 3 months ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 1 year 3 months ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
PRESS RELEASE published on 02/21/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
BRIEF published on 02/20/2025 at 07:35, 1 year 3 months ago Sensorion to Participate in March Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Loss Therapies March 2025
PRESS RELEASE published on 02/20/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases Sensorion announces participation in investor conferences in March. CEO and CFO will attend Cowen and Leerink events to present company updates and meet investors Biotechnology CFO Investor Conferences CEO Sensorion
BRIEF published on 02/18/2025 at 07:35, 1 year 4 months ago Sensorion announces its participation in congresses in March 2025 Biotechnology Sensorion Hearing Therapies Medical Innovations Congress 2025
PRESS RELEASE published on 02/18/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces participation in upcoming congresses in March to present on innovative biologics and manufacturing challenges for hearing loss disorders Sensorion Hearing Loss Biologics Congresses Manufacturing Challenges
BRIEF published on 02/12/2025 at 11:35, 1 year 4 months ago Sensorion to Participate in ARO 48th Annual Midwinter Meeting Sensorion Hearing Loss ARO Meeting GJB2-GT Therapy Biotech Conference
Published on 06/18/2026 at 14:30, 36 minutes ago Voting Results from Solitario Resources Corp Annual Meeting Held June 17, 2026
Published on 06/18/2026 at 14:30, 36 minutes ago Rochon Family Executes Strategic Purchase of AIAI Holdings Shares
Published on 06/18/2026 at 14:25, 41 minutes ago Sparton Acquires Option to Past Producing Silver Property and Strengthens Board at AGM
Published on 06/18/2026 at 14:01, 1 hour 5 minutes ago Worksport (NASDAQ:WKSP) Announces $1.20 per Share Direct Investment at 100% Premium to Market; Institutional Investor Signals Interest in Up to $10 Million
Published on 06/18/2026 at 14:00, 1 hour 6 minutes ago EQ Works Expands Multi-Year Partnership with Leading Canadian Publisher to Include SaaS License for ClearLake
Published on 06/18/2026 at 13:05, 2 hours ago Claros Technologies Appoints Jack Cogen to Board of Directors
Published on 06/18/2026 at 13:05, 2 hours ago MMDSmart MessageWhiz Launches On Zoho Marketplace To Extend Automated Omnichannel Messaging Inside Zoho CRM
Published on 06/18/2026 at 12:55, 2 hours 10 minutes ago FP Markets Wins Most Trusted Broker at the Global UF Awards 2026
Published on 06/18/2026 at 12:45, 2 hours 20 minutes ago Hong Kong rises to No.2 globally in competitiveness
Published on 06/18/2026 at 12:12, 2 hours 53 minutes ago Form 8.3 - Advanced Medical Solutions Group Plc
Published on 06/18/2026 at 09:06, 5 hours 59 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 6 hours 36 minutes ago OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 8 hours 6 minutes ago bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 21 hours 26 minutes ago Report on share repurchases from 10 to 16 June 2026
